About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gbx2tm1.1Mrt
targeted mutation 1.1, Gail R Martin
MGI:1857634
Summary 12 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt B6.129-Gbx2tm1.1Mrt MGI:3663465
hm2
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J) or (involves: 129S1/Sv * 129X1/SvJ * FVB/N) MGI:2176961
hm3
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt involves: 129S1/Sv * 129X1/SvJ * Swiss Webster MGI:3698553
ht4
Gbx2tm1.1Mrt/Gbx2tm1.2Alj involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ MGI:5499542
ht5
Gbx2tm1.1Mrt/Gbx2tm1.1Alj involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL MGI:3790204
ht6
Gbx2tm1.1(cre/ERT2)Jyhl/Gbx2tm1.1Mrt involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL MGI:3840449
cn7
Gbx2tm1.1(cre/ERT2)Jyhl/Gbx2tm1.1Mrt
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL MGI:3840450
cn8
En1tm2(cre)Wrst/En1+
Gbx2tm1.1Mrt/Gbx2tm1.1Alj
involves: 129/Sv * C57BL/6 * SJL * Swiss Webster MGI:3790208
cx9
Gbx2tm1.1Mrt/Gbx2+
Fgf8tm1.4Mrt/Fgf8+
B6.129-Gbx2tm1.1Mrt Fgf8tm1.4Mrt MGI:3664073
cx10
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Fgf8tm1.4Mrt/Fgf8+
B6.129-Gbx2tm1.1Mrt Fgf8tm1.4Mrt MGI:3664074
cx11
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Otx2tm1Pas/Otx2tm2Asim
involves: 129 * C57BL/6 * DBA/2 MGI:3845546
cx12
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Otx2tm1(OTX1)Asim/Otx2tm1(OTX1)Asim
involves: 129 * C57BL/6 * DBA/2 MGI:3845545


Genotype
MGI:3663465
hm1
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Genetic
Background
B6.129-Gbx2tm1.1Mrt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes survive to birth, but die soon afterwards

cardiovascular system
• ~39% of homozygotes exhibit cardiovascular defects that affect development of the fourth PAAs and proper alignment of the conus (not observed in wild-type or heterozygous mice)
• at E10.5, homozygotes show absence (nonpatent to ink) or hypoplasia of the left, right, or both fourth PAAs, with infrequent loss of the left sixth PAA and persistence of the right sixth PAA and descening aorta
• however, no defects in the development of the third PAA are observed, and initial pharyngeal arch segmentation appears unaffected
• at E10.5, endothelial cells are poorly organized in the mutant fourth PAA
• 21% of homozygotes with cardiac defects exhibit a retroesophageal right subclavian artery
• 26% of homozygotes with cardiac defects show interrupted aortic arch (IAA) type B, whereby the segment between the left common carotid artery and left subclavian artery is absent
• 37% of homozygotes with cardiac defects display right aortic arch (RAA) with a right ductus arteriosus and persistence of the right descending aorta
• at E10.5, homozygotes show poor organization of endothelial cells in the fourth PAA
• 16% of homozygotes with cardiac defects display a double outlet right ventricle
• 16% of homozygotes with cardiac defects exhibit an overriding aorta
• mutant hearts with an overriding aorta display a mebraneous septal defect
• however, no VSDs are present in hearts with isolated arterial remodeling defects (IAA, RAA)

craniofacial
• at E10.5, homozygotes show absence (nonpatent to ink) or hypoplasia of the left, right, or both fourth PAAs, with infrequent loss of the left sixth PAA and persistence of the right sixth PAA and descening aorta
• however, no defects in the development of the third PAA are observed, and initial pharyngeal arch segmentation appears unaffected
• at E10.5, endothelial cells are poorly organized in the mutant fourth PAA
• at E18.5, homozygotes display ectopic fusion of the styloid process with the base of the incus
• at E18.5, 2 of 5 homozygotes display a severely hypoplastic styloid process
• at E18.5, homozygotes display ectopic fusion of the styloid process with the base of the incus
• at E18.5, 2 of 5 homozygotes display severely hypoplastic middle ear components, including the incus and malleus, as well as the styloid process and the stapes
• homozygotes infrequently exhibit a cleft palate

embryo
• at E10.5, homozygotes show absence (nonpatent to ink) or hypoplasia of the left, right, or both fourth PAAs, with infrequent loss of the left sixth PAA and persistence of the right sixth PAA and descening aorta
• however, no defects in the development of the third PAA are observed, and initial pharyngeal arch segmentation appears unaffected
• at E10.5, endothelial cells are poorly organized in the mutant fourth PAA
• at E9-E9.5, 4 of 6 homozygotes show significantly reduced migrating NCCs, esp. post-otic NCCs entering caudal pharyngeal arches (region of developing fourth PAAs)
• fourth PAA defects precede smooth muscle cell differentiation
• at E10.5, NCCs are underrepresented in the mutant fourth PAAs

homeostasis/metabolism
• homozygous mutant pups appear cyanotic at birth

nervous system
• fourth PAA defects precede smooth muscle cell differentiation
• at E10.5, NCCs are underrepresented in the mutant fourth PAAs
• all homozygotes display cerebellar defects similar to those described in J:42110
• at E10.5, most homozygotes show ectopic projections between the trigeminal and the facial nerves
• the mutant trigeminal ganglion is shifted ventrally directly behind the eye
• at E10.5, 3 of 4 homozygotes display fusion of the 9th (glossopharyngeal) and 10th (vagus) cranial nerves, just posterior to the otocyst

hearing/vestibular/ear
• at E18.5, homozygotes display ectopic fusion of the styloid process with the base of the incus
• at E18.5, 2 of 5 homozygotes display severely hypoplastic middle ear components, including the incus and malleus, as well as the styloid process and the stapes
• at E18.5, all homozygotes exhibit a severely hypoplastic otic capsule

skeleton
• at E18.5, homozygotes display ectopic fusion of the styloid process with the base of the incus
• at E18.5, 2 of 5 homozygotes display a severely hypoplastic styloid process
• at E18.5, homozygotes display ectopic fusion of the styloid process with the base of the incus
• at E18.5, 2 of 5 homozygotes display severely hypoplastic middle ear components, including the incus and malleus, as well as the styloid process and the stapes

digestive/alimentary system
• homozygotes infrequently exhibit a cleft palate

cellular
• at E10.5, homozygotes show poor organization of endothelial cells in the fourth PAA
• at E9-E9.5, 4 of 6 homozygotes show significantly reduced migrating NCCs, esp. post-otic NCCs entering caudal pharyngeal arches (region of developing fourth PAAs)

growth/size/body
• homozygotes infrequently exhibit a cleft palate




Genotype
MGI:2176961
hm2
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Genetic
Background
either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J) or (involves: 129S1/Sv * 129X1/SvJ * FVB/N)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes are present at a normal Mendelian frequency at E18.5 but die soon after birth

nervous system
• some homozygotes display a severely abnormal forebrain development
• at E14.5, the normal thick to thin transition of neuroepithelium marking the mid/hindbrain junction is found caudal to its normal location, suggesting that the mutant posterior midbrain may extend caudally
• in addition, the mutant posterior midbrain exhibits aberrant A-P patterning
• at E12.5, normal derivatives of the isthmus (isthmic nuclei; IV motor nucleus) and r1-3 (cerebellum, locus coeruleus, V motor nucleus) fail to develop
• however, no defects in brain or spinal cord derivatives of regions posterior to r3 are noted from E12.5 through P0
• at E14.5-E16.5, the junction between the midbrain and developing cerebellum (isthmus) is more caudally positioned than normal
• at E9.5-E10.5, the neuroepithelium at the mid/hindbrain junction is abnormal on its posterior side
• by E9.5, the region between the posterior end of the midbrain and r4 (i.e. anterior hindbrain) is severely reduced in length
• at E14.5-E16.5, the developing choroid plexus appears to be fused to the amorphous tissue found in place of a normal cerebellum
• by E17.5-P0, the mutant choroid plexus is abnormally small and structurally underdeveloped
• at E14.5, the inferior colliculus of the dorsal midbrain appears as a thickened, extended tissue that resembles the superior colliculus
• at E9.5-E10.5, the anterior hindbrain is significantly reduced along the A-P axis and its ventral wall is morphologically abnormal
• at E9.5-E10.5, the neuroepithelium at the mid/hindbrain junction is abnormal on its posterior side
• anterior hindbrain defects can be traced back to an early stage of neuraxis development (at least E8.5) and are noted as early as E7.75
• at E9.5-E10.5, the anterior hindbrain is significantly reduced along the A-P axis and its ventral wall is morphologically abnormal
• anterior hindbrain defects can be traced back to an early stage of neuraxis development (at least E8.5) and are noted as early as E7.75
• at E12.5-E13.5, the region caudal to the midbrain that includes the cerebellar anlage is reduced in A-P length and appears disorganized
• at E17.5-P0, the wall of the rostral pontine region is unusually thin, with abnormal architecture
• at E14.5-E16.5, the locus coeruleus, which is derived from r1, is absent
• at E14.5-E16.5, all homozygotes exhibit a reduced and morphologically abnormal structure in place of a developing cerebellum
• by E17.5-P0, homozygotes display a small amorphous tissue of variable size and morphology instead of a normal cerebellum in the anterior hindbrain
• at E14.5-E16.5, the IV motor nucleus and V motor nucleus, which are derived from the isthmus and r2/r3, respectively, are absent
• in contrast, the III motor nucleus in the midbrain, and the VII motor nucleus, which forms in r4/r5 and then migrates to r6 are present and appear normal

hearing/vestibular/ear
• at E9.5-E10.5, mutant otocysts are smaller and laterally displaced, in abnormal proximity to the midbrain
• some mutant embryos exhibit abnormal development of the dorsal membranous labyrinth

craniofacial
• some mutant embryos show a significantly reduced or absent supraoccipital bone

skeleton
• some mutant embryos show a significantly reduced or absent supraoccipital bone




Genotype
MGI:3698553
hm3
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hearing/vestibular/ear
• at E9 to E9.5, some homozygotes display a reduced otocyst size
• at E15.5, homozygotes display variable inner ear phenotypes divided into four categories, with increasing severity from Type I to IV
• Type I homozygotes exhibit an enlarged membranous labyrinth which lacks the endolymphatic duct in 3/4 cases
• Type II homozygotes show absence of both the endolymphatic duct (7/7) and common crus (5/7); the utricle and saccule are not easily discernible, and the cochlear duct is shortened
• Type III homozygotes lack the anterior and posterior canals and show less than one coil, in addition to phenotypes described for Type II
• Type IV homozygotes display a cystic inner ear with only a lateral canal and ampulla in 3/5 cases
• in 8 of 10 cases, the two ears of a given specimen usually display similar phenotypes
• Type IV (i.e most severely affected) homozygotes exhibit cystic inner ears without any discernible structures except for the presence of a lateral canal in some cases (3/5)
• at E15.5, Type III homozygotes exhibit less than one coil
• overall, 68% (13 of 19) homozygotes lack a common crus (that is, five Type II, three Type III and five Type IV mutants)
• overall, 11% (2 of 19) homozygotes lack a lateral canal and ampulla (only Type IV mutants)
• overall, 42% (8 of 19) homozygotes lack a posterior canal (that is, three Type III and five Type IV mutants)
• overall, 21% (4 of 19) homozygotes lack an anterior ampulla (that is, one Type III and three Type IV mutants)
• at E15.5, anterior and posterior cristae are generally present, except in some of Type IV specimens
• overall, 42% (8 of 19) homozygotes lack an anterior canal (that is, three Type III and five Type IV mutants)
• overall, 21% (4 of 19) homozygotes lack an anterior ampulla (that is, one Type III and three Type IV mutants)
• overall, 18 of 19 homozygous mutant inner ears display an enlarged membranous labyrinth at E15.5
• at E15.5, the organ of Corti is severely affected in most mutants, with only one or two small sensory patches even in Type II mice
• overall, 26% (5 of 19) homozygotes lack a cochlear duct (only Type IV mutants)
• absence of cochlear duct extension is evident by E11.5
• at E15.5, the saccular maccula is severely affected in most mutants, with no discernible sensory patches even in Type II mice
• overall, 42% (8 of 19) homozygotes lack a saccule (that is, one Type I, one Type II, two Type III and four Type IV mutants)
• overall, 95% (18 of 19) homozygous mutant inner ears lack an endolymphatic duct at E15.5
• absence of the endolymphatic duct is also noted at E11.5

nervous system
• the anterior hindbrain rostral to r4 is missing and is replaced by an ill-defined zone with aberrant gene expression patterns
• in addition, development of the caudal hindbrain is disrupted, as shown by changes in gene expression patterns caudal to r3
• at E9 to E9.5, r5 is abnormal based on gene expression patterns
• the anterior hindbrain rostral to r4 is missing and is replaced by an ill-defined zone with aberrant gene expression patterns
• at E15.5, the spiral ganglion is present in most Type II specimens (2/3) but missing in 2/2 Type IV specimens
• TUNEL analysis indicates elevated apoptosis in the cochleo-vestibular ganglion at E9.5-E10.5
• missing in 2/2 Type IV specimens

embryo
• at E9 to E9.5, r5 is abnormal based on gene expression patterns

growth/size/body
• Type IV (i.e most severely affected) homozygotes exhibit cystic inner ears without any discernible structures except for the presence of a lateral canal in some cases (3/5)




Genotype
MGI:5499542
ht4
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.2Alj
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
Gbx2tm1.2Alj mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

nervous system
• authors state that mice resemble Gbx2tm1.1Mrt homozygotes at E18.5

cardiovascular system
• authors state that mice resemble Gbx2tm1.1Mrt homozygotes at E18.5

skeleton
• authors state that mice resemble Gbx2tm1.1Mrt homozygotes at E18.5




Genotype
MGI:3790204
ht5
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.1Alj
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1Alj mutation (1 available); any Gbx2 mutation (27 available)
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• no abnormal phenotypes are observed in homozygous mice




Genotype
MGI:3840449
ht6
Allelic
Composition
Gbx2tm1.1(cre/ERT2)Jyhl/Gbx2tm1.1Mrt
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1(cre/ERT2)Jyhl mutation (1 available); any Gbx2 mutation (27 available)
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• at E18.5




Genotype
MGI:3840450
cn7
Allelic
Composition
Gbx2tm1.1(cre/ERT2)Jyhl/Gbx2tm1.1Mrt
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1(cre/ERT2)Jyhl mutation (1 available); any Gbx2 mutation (27 available)
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
Gt(ROSA)26Sortm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• at E14.5, cells expressing lacZ are found across the dorsal and posterior borders of the thalamus expanding into the epithalamus and pretectum
• ectopic lacZ expressing cells from the thalamus are mainly found in the lateral habenular nuclei and anterior part of the pretectum at E18.5
• at E10.5 the thalamus is smaller in the mediolateral dimension and larger in the ventrodorsal dimension
• thalamus morphology is severely disrupted after E14.5




Genotype
MGI:3790208
cn8
Allelic
Composition
En1tm2(cre)Wrst/En1+
Gbx2tm1.1Mrt/Gbx2tm1.1Alj
Genetic
Background
involves: 129/Sv * C57BL/6 * SJL * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm2(cre)Wrst mutation (1 available); any En1 mutation (34 available)
Gbx2tm1.1Alj mutation (1 available); any Gbx2 mutation (27 available)
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• more than half of the mice survive past weaning, are fertile and nurture their offspring normally
• some mutants are found dead prior to weaning age

growth/size/body
• surviving mutants weigh less than wild-type littermates
• surviving mutants (adults) are smaller than littermates

nervous system
N
• cerebellar hemisphere development and cytoarchitecture of cerebellum are essentially normal
• at E12.5, neuroepithelium of medial cerebellar anlage is thinner than in wild-type with abnormal indents found in the ventricular layer
• at E10.5, mesencephalon is expanded caudally and alar plate of r1 is significantly reduced
• medial region of cerebellar primordium is reduced in size from E12.5 to 18.5
• increased cell proliferation is observed in indents into ventricular layer, resulting in small cell aggregates in ventricular layer at E14.5; large cell aggregates are observed in medial cerebella of mutants at E18.5
• however, no cell aggregates are seen in cerebella of 8-week old mutants
• foliation pattern is disrupted in adults
• in adult mutants all lobules are reduced in size to varying extents with lobules V and IX less affected
• at E10.5, the mesencephalon is expanded caudally
• at E9.5, isthmic constriction dividing the mesencephalon and rhombomere 1 (r1) at dorsal midline is less prominent than in wild-type
• proliferation in the medial region of the cerebellum is reduced compared to wild-type

embryo
• at E12.5, neuroepithelium of medial cerebellar anlage is thinner than in wild-type with abnormal indents found in the ventricular layer




Genotype
MGI:3664073
cx9
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2+
Fgf8tm1.4Mrt/Fgf8+
Genetic
Background
B6.129-Gbx2tm1.1Mrt Fgf8tm1.4Mrt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1.4Mrt mutation (0 available); any Fgf8 mutation (21 available)
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• ~16% of double heterozygotes exhibit PAA-related cardiovascular defects vs 0% in single Gbx2tm1Mrt or Fgf8tm1.4Mrt heterozygotes
• however, no incidences of a double outlet right ventricle, an overriding aorta or a retroesophageal right subclavian artery are observed
• 20% of double heterozygotes with cardiovascular defects display a retroesophageal right subclavian artery
• 80% of double heterozygotes with cardiovascular defects exhibit a right aortic arch

craniofacial
• ~16% of double heterozygotes exhibit PAA-related cardiovascular defects vs 0% in single Gbx2tm1Mrt or Fgf8tm1.4Mrt heterozygotes
• however, no incidences of a double outlet right ventricle, an overriding aorta or a retroesophageal right subclavian artery are observed

embryo
• ~16% of double heterozygotes exhibit PAA-related cardiovascular defects vs 0% in single Gbx2tm1Mrt or Fgf8tm1.4Mrt heterozygotes
• however, no incidences of a double outlet right ventricle, an overriding aorta or a retroesophageal right subclavian artery are observed




Genotype
MGI:3664074
cx10
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Fgf8tm1.4Mrt/Fgf8+
Genetic
Background
B6.129-Gbx2tm1.1Mrt Fgf8tm1.4Mrt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1.4Mrt mutation (0 available); any Fgf8 mutation (21 available)
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• mutant mice exhibit a significantly increased frequency, but not severity, of PAA-related cardiovascular defects relative to single Gbx2tm1Mrt homozygotes (86% vs 39%, respectively)
• however, no incidences of a double outlet right ventricle or an overriding aorta are observed
• 16.6% of mutant mice with cardiovascular defects exhibit a retroesophageal right subclavian artery vs 21% of single Gbx2tm1Mrt homozygotes
• 25% of mutant mice with cardiovascular defects exhibit an interrupted aortic arch (IAA) type B vs 26% of single Gbx2tm1Mrt homozygotes
• 58.3% of mutant mice with cardiovascular defects exhibit a right aortic arch (RAA) vs 37% of single Gbx2tm1Mrt homozygotes

hematopoietic system
• ~29% of mutant mice exhibit abnormal thymus development, either as a single-lobed thymus or as an overall reduction in thymus size (not observed in single Gbx2tm1Mrt homozygotes or Fgf8tm1.4Mrt heterozygotes)

immune system
• ~29% of mutant mice exhibit abnormal thymus development, either as a single-lobed thymus or as an overall reduction in thymus size (not observed in single Gbx2tm1Mrt homozygotes or Fgf8tm1.4Mrt heterozygotes)

craniofacial
• mutant mice exhibit a significantly increased frequency, but not severity, of PAA-related cardiovascular defects relative to single Gbx2tm1Mrt homozygotes (86% vs 39%, respectively)
• however, no incidences of a double outlet right ventricle or an overriding aorta are observed
• a few mutant mice display a reduced mandible
• a few mutant mice exhibit small external ears

hearing/vestibular/ear
• a few mutant mice exhibit small external ears

skeleton
• a few mutant mice display a reduced mandible

embryo
• mutant mice exhibit a significantly increased frequency, but not severity, of PAA-related cardiovascular defects relative to single Gbx2tm1Mrt homozygotes (86% vs 39%, respectively)
• however, no incidences of a double outlet right ventricle or an overriding aorta are observed
• at E9.5, mutant mice display a NCC migratory patterning defect similar to that of single Gbx2tm1Mrt homozygotes

cellular
• at E9.5, mutant mice display a NCC migratory patterning defect similar to that of single Gbx2tm1Mrt homozygotes

endocrine/exocrine glands
• ~29% of mutant mice exhibit abnormal thymus development, either as a single-lobed thymus or as an overall reduction in thymus size (not observed in single Gbx2tm1Mrt homozygotes or Fgf8tm1.4Mrt heterozygotes)

growth/size/body
• a few mutant mice exhibit small external ears




Genotype
MGI:3845546
cx11
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Otx2tm1Pas/Otx2tm2Asim
Genetic
Background
involves: 129 * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
Otx2tm1Pas mutation (2 available); any Otx2 mutation (50 available)
Otx2tm2Asim mutation (1 available); any Otx2 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• mice are viable at E10.5

nervous system
• brain development is compromised
• however, mice exhibit rescue of the anterior defects observed in Otx2tm1(OTX1)Asim/Otx2tm1Pas heterozygotes

cardiovascular system
N
• heart development is normal

growth/size/body
• head development is compromised




Genotype
MGI:3845545
cx12
Allelic
Composition
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt
Otx2tm1(OTX1)Asim/Otx2tm1(OTX1)Asim
Genetic
Background
involves: 129 * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gbx2tm1.1Mrt mutation (0 available); any Gbx2 mutation (27 available)
Otx2tm1(OTX1)Asim mutation (1 available); any Otx2 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• although present at E9.5, no mice are detected at E10 to E10.5

nervous system
• at E9.7, mice fail to exhibit regionalization of the anterior neural plate unlike wild-type mice
• at E9.7, the distance between the otic vesicle and the rostral tip of the embryo is greater than in wild-type embryos
• at E9.7, the anterior neuroectoderm is abnormal
• at E9.7, telencephalic vesicles are not recognizable
• at E9.7, the isthmic constriction is not recognizable

cardiovascular system
• at E9.7

embryo
• at E9.7, mice fail to exhibit regionalization of the anterior neural plate unlike wild-type mice
• at E9.7, the distance between the otic vesicle and the rostral tip of the embryo is greater than in wild-type embryos
• at E9.7, the anterior neuroectoderm is abnormal

craniofacial

growth/size/body

respiratory system

taste/olfaction

vision/eye
• at E9.7, the optic placodes are absent
• at E9.7, optic vesicles are not recognizable





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory